Literature DB >> 31695737

The role of a critical care outreach service in the management of patients with haematological malignancy.

Leila Taheri1, Rathai Anandanadesan2, Hugues de Lavallade3, Eirini Pagkalidou4, Antonio Pagliuca3, Ghulam Mufti3, Georg Auzinger5, Victoria Metaxa5.   

Abstract

INTRODUCTION: Although improvement in survival from haematological malignancies has been reported, a substantial number of these patients develop life threatening complications. Critical care outreach services (CCOS) aim to avert inappropriate ICU admissions, while ensuring timely patient review.
METHODS: We retrospectively analysed patients with haematological malignancy reviewed by an outreach service between January 2014 and December 2015 at a single institution. The aim of our study was to describe the patient population assessed by a well-established outreach team, identify predictors of ICU admission, as well as ICU and hospital mortality.
RESULTS: Sixty of 126 patients reviewed (47.6%) were admitted to ICU. ICU and hospital mortality were 25.3% and 45.2%, respectively. The odds of being admitted to ICU was 13 times higher (p = 0.013) if the patient was referred for hypoxia, 20 times higher (p = 0.006) if they were referred for sepsis or 14 times higher (p = 0.027) if they were referred to CCOS for hypotension, compared to when the team was automatically alerted. The odds of not surviving hospital admission increased 1.27 times for every extra day of CCOS review (p = 0.02). When a patient was referred having a refractory or progressive haematological condition, the odds of not surviving to hospital discharge increased by four or 12 times, respectively, compared to when the referred patient was in remission. Receiving high flow nasal cannula oxygen (HFNCO) was associated with a reduction in ICU admission (p = 0.03), irrespective of the underlying diagnosis, performance status or location of delivery. The CCOS participated in end-of-life discussions in 29% patients.
CONCLUSIONS: ICU and hospital mortality of patients with haemato-oncological malignancy continue to improve. CCOS are heavily involved in the recognition and management of these patients, as well as in the facilitation of end-of-life discussions. Sepsis was associated with increased risk of ICU admission and mortality. Initiation of HFNCO outside ICU appears to be feasible and safe and was not associated with increasing risk in this single centre study. © The Intensive Care Society 2019.

Entities:  

Keywords:  Critical care; haematological malignancy; intensive care unit; palliative care; patient admission

Year:  2019        PMID: 31695737      PMCID: PMC6820225          DOI: 10.1177/1751143719855201

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  37 in total

1.  The variability of critical care bed numbers in Europe.

Authors:  A Rhodes; P Ferdinande; H Flaatten; B Guidet; P G Metnitz; R P Moreno
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

Review 2.  Managing critically Ill hematology patients: Time to think differently.

Authors:  Elie Azoulay; Frédéric Pène; Michael Darmon; Etienne Lengliné; Dominique Benoit; Marcio Soares; Francois Vincent; Fabrice Bruneel; Pierre Perez; Virginie Lemiale; Djamel Mokart
Journal:  Blood Rev       Date:  2015-04-26       Impact factor: 8.250

3.  Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.

Authors:  Byung Ju Kang; Younsuck Koh; Chae-Man Lim; Jin Won Huh; Seunghee Baek; Myongja Han; Hyun-Suk Seo; Hee Jung Suh; Ga Jin Seo; Eun Young Kim; Sang-Bum Hong
Journal:  Intensive Care Med       Date:  2015-02-18       Impact factor: 17.440

Review 4.  Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.

Authors:  G T Bird; P Farquhar-Smith; T Wigmore; M Potter; P C Gruber
Journal:  Br J Anaesth       Date:  2012-01-31       Impact factor: 9.166

5.  Intensive care unit experience of haemopoietic stem cell transplant patients.

Authors:  S Agarwal; S O'Donoghue; J Gowardman; G Kennedy; H Bandeshe; R Boots
Journal:  Intern Med J       Date:  2012-07       Impact factor: 2.048

6.  Thirty-day mortality in critical care outreach patients with cancer: an investigative study of predictive factors related to outreach referral episodes.

Authors:  Natalie Pattison; Sue Ashley; Paul Farquhar-Smith; Lara Roskelly; Geraldine O'Gara
Journal:  Resuscitation       Date:  2010-08-12       Impact factor: 5.262

Review 7.  Variation in critical care services across North America and Western Europe.

Authors:  Hannah Wunsch; Derek C Angus; David A Harrison; Olivier Collange; Robert Fowler; Eric A J Hoste; Nicolette F de Keizer; Alexander Kersten; Walter T Linde-Zwirble; Alberto Sandiumenge; Kathryn M Rowan
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

8.  Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.

Authors:  Syed W I Bokhari; Talha Munir; Shabeeha Memon; Jenny L Byrne; Nigel H Russell; Martin Beed
Journal:  Ann Hematol       Date:  2009-10-30       Impact factor: 3.673

Review 9.  Clinical review: the role of the intensivist and the rapid response team in nosocomial end-of-life care.

Authors:  Andrew K Hilton; Daryl Jones; Rinaldo Bellomo
Journal:  Crit Care       Date:  2013-04-26       Impact factor: 9.097

10.  Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease.

Authors:  Kaito Harada; Shuhei Kurosawa; Yutaro Hino; Keita Yamamoto; Masahiro Sakaguchi; Shuntaro Ikegawa; Keiichro Hattori; Aiko Igarashi; Kyoko Watakabe; Yasushi Senoo; Yuho Najima; Takeshi Hagino; Noriko Doki; Takeshi Kobayashi; Kazuhiko Kakihana; Toshihiro Iino; Hisashi Sakamaki; Kazuteru Ohashi
Journal:  Springerplus       Date:  2016-04-23
View more
  1 in total

1.  A critical care outreach team under strain - Evaluation of the service provided to patients with haematological malignancy during the Covid-19 pandemic.

Authors:  Emma Prower; Sophie Hadfield; Rohit Saha; Timothy Woo; Kar Mun Ang; Victoria Metaxa
Journal:  J Crit Care       Date:  2022-07-15       Impact factor: 4.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.